N/A
N=107
The Dynamics of Human Atrial Fibrillation
Atrial Fibrillation · Atrial Tachyarrhythmia
Bottom Line
View on ClinicalTrials.gov: NCT01008722 ↗Enrolled (actual)
107
Serious AEs
7.5%
Results posted
Feb 2017
Primary outcome: Primary: Survival Free of Atrial Fibrillation — 28; 31 participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Adult, Older Adult · 21+ yrs
- Sex
- All
- Sponsor
- University of California, San Diego
- Primary completion
- Apr 2014
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Survival Free of Atrial Fibrillation |
28; 31 | — |
| SECONDARY Termination or Slowing of Atrial Fibrillation During Ablation |
31; 13 | — |
Summary
The study is conducted in patients with atrial fibrillation undergoing clinically prescribed ablation. The study hypothesis is that ablation at specific sites that are identified to 'drive' the atrial fibrillation may improve the success of the ablation procedure.
Eligibility Criteria
Inclusion Criteria
- Subjects will be patients undergoing electrophysiology study and ablation for paroxysmal or persistent atrial fibrillation (AF) after having failed >or= 1 anti-arrhythmic drug.
Data sourced from ClinicalTrials.gov (NCT01008722). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.